The status and influencing factors of abnormal fetal pregnancy outcomes in 265 cases in China: a retrospective study.


Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2024
Historique:
received: 28 12 2023
accepted: 01 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 30 4 2024
Statut: epublish

Résumé

With the advancement of prenatal diagnosis technology, the detection rate of fetal abnormalities continues to increase, imposing a significant burden on both society and families. A retrospective analysis of essential information about pregnant women, such as their pregnancy history and delivery details, is crucial for understanding the primary factors that influence pregnancy outcomes in women with fetal abnormalities. This analysis is of great significance for improving the level of pregnancy management and outcomes in pregnant women with fetal abnormalities. To retrospectively analyze the pregnancy outcomes of women with fetal abnormalities and explore the factors that influence these outcomes. Pregnant women's pregnancy outcomes were collected from the medical information system and through telephone follow-ups. The chi-square test and logistic regression were used to analyze the factors influencing pregnancy outcomes. Among 265 pregnant women diagnosed with fetal abnormalities, 190 chose to continue the pregnancy, while 75 chose to terminate it. Pregnant women with multiple fetal abnormalities (OR = 3.774, 95% CI [1.640-8.683]) were more likely to choose termination of pregnancy (TOP), and pregnant women who were advised to terminate their pregnancy or make a careful choice were more likely to terminate the pregnancy (OR = 41.113, 95% CI [11.028-153.267]). The number of organs involved in fetal abnormalities and treatment recommendations were identified as the primary factors influencing pregnancy outcomes. Improving awareness of maternal health care during pregnancy, early pregnancy screening technology, and a multidisciplinary diagnosis and treatment approach are of great significance in assisting pregnant women in making informed decisions and improving fetal prognosis.

Sections du résumé

Background UNASSIGNED
With the advancement of prenatal diagnosis technology, the detection rate of fetal abnormalities continues to increase, imposing a significant burden on both society and families. A retrospective analysis of essential information about pregnant women, such as their pregnancy history and delivery details, is crucial for understanding the primary factors that influence pregnancy outcomes in women with fetal abnormalities. This analysis is of great significance for improving the level of pregnancy management and outcomes in pregnant women with fetal abnormalities.
Objective UNASSIGNED
To retrospectively analyze the pregnancy outcomes of women with fetal abnormalities and explore the factors that influence these outcomes.
Methods UNASSIGNED
Pregnant women's pregnancy outcomes were collected from the medical information system and through telephone follow-ups. The chi-square test and logistic regression were used to analyze the factors influencing pregnancy outcomes.
Results UNASSIGNED
Among 265 pregnant women diagnosed with fetal abnormalities, 190 chose to continue the pregnancy, while 75 chose to terminate it. Pregnant women with multiple fetal abnormalities (OR = 3.774, 95% CI [1.640-8.683]) were more likely to choose termination of pregnancy (TOP), and pregnant women who were advised to terminate their pregnancy or make a careful choice were more likely to terminate the pregnancy (OR = 41.113, 95% CI [11.028-153.267]).
Conclusion UNASSIGNED
The number of organs involved in fetal abnormalities and treatment recommendations were identified as the primary factors influencing pregnancy outcomes. Improving awareness of maternal health care during pregnancy, early pregnancy screening technology, and a multidisciplinary diagnosis and treatment approach are of great significance in assisting pregnant women in making informed decisions and improving fetal prognosis.

Identifiants

pubmed: 38685940
doi: 10.7717/peerj.17284
pii: 17284
pmc: PMC11057424
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17284

Informations de copyright

© 2024 Ruan et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

BJOG. 2008 May;115(6):689-96
pubmed: 18410651
Dev Med Child Neurol. 2022 Jan;64(1):23-39
pubmed: 34482539
J Matern Fetal Neonatal Med. 2014 Sep;27(13):1301-4
pubmed: 24134633
Contraception. 2012 Jan;85(1):63-8
pubmed: 22067803
Pediatrics. 2004 Apr;113(4 Suppl):957-68
pubmed: 15060188
Front Public Health. 2022 Dec 06;10:1008028
pubmed: 36561870
Acta Obstet Gynecol Scand. 2017 Feb;96(2):176-182
pubmed: 27714775
China CDC Wkly. 2021 Sep 10;3(37):771-772
pubmed: 34594987
BMC Pregnancy Childbirth. 2022 Jun 13;22(1):480
pubmed: 35698102
Eur J Med Genet. 2018 Sep;61(9):493-498
pubmed: 29777898
Am J Obstet Gynecol. 2005 Oct;193(4):1492-7
pubmed: 16202745
Pediatr Radiol. 2018 Apr;48(4):457-460
pubmed: 29550868
Ultrasound Obstet Gynecol. 2017 Oct;50(4):429-441
pubmed: 27546497
BMC Pregnancy Childbirth. 2022 Mar 15;22(1):210
pubmed: 35291955
Prenat Diagn. 2019 Jul;39(8):595-602
pubmed: 31063215
Prenat Diagn. 2023 Jan;43(1):95-101
pubmed: 36443507
Pediatr Dev Pathol. 2019 Nov-Dec;22(6):546-557
pubmed: 31256740
Public Health Nutr. 2015 Mar;18(4):582-8
pubmed: 24844654
Obstet Gynecol. 2002 Feb;99(2):216-22
pubmed: 11814500
World J Pediatr. 2011 Nov;7(4):302-10
pubmed: 22015723
Pediatrics. 2022 Nov 1;150(Suppl 2):
pubmed: 36317976
Cells. 2021 Nov 05;10(11):
pubmed: 34831248
Semin Fetal Neonatal Med. 2018 Apr;23(2):102-111
pubmed: 29233624
BMC Pregnancy Childbirth. 2022 Dec 17;22(1):948
pubmed: 36528557
BMC Pregnancy Childbirth. 2022 May 26;22(1):441
pubmed: 35619067
PLoS Med. 2020 Feb 24;17(2):e1003047
pubmed: 32092053
West Afr J Med. 2021 Sep 7;38(8):738-742
pubmed: 34499832
Paediatr Perinat Epidemiol. 2022 Nov;36(6):804-814
pubmed: 35821640
Prenat Diagn. 2020 Jul;40(8):925-930
pubmed: 31955435
Prenat Diagn. 2014 Jul;34(7):660-7
pubmed: 24810468
J Korean Med Sci. 2019 Jun 24;34(24):e170
pubmed: 31222983

Auteurs

Jing Ruan (J)

Department of Nursing, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.

Xuemei Zhong (X)

Breast Surgery, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.

Jiaxuan Mai (J)

Neonatal Surgery Department, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.

Cuifen Liu (C)

Fetal Life Cycle Clinic, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.

Huiyang Ding (H)

Neonatal Surgery Department, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH